Logo image of BZ

KANZHUN LTD - ADR (BZ) Stock Fundamental Analysis

NASDAQ:BZ - Nasdaq - US48553T1060 - ADR - Currency: USD

13.52  -0.38 (-2.73%)

Fundamental Rating

6

Taking everything into account, BZ scores 6 out of 10 in our fundamental rating. BZ was compared to 70 industry peers in the Interactive Media & Services industry. While BZ has a great health rating, its profitability is only average at the moment. BZ has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BZ had positive earnings in the past year.
In multiple years BZ reported negative net income over the last 5 years.
Of the past 5 years BZ 4 years had a positive operating cash flow.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

BZ has a better Return On Assets (8.21%) than 87.14% of its industry peers.
BZ's Return On Equity of 10.59% is amongst the best of the industry. BZ outperforms 88.57% of its industry peers.
BZ has a Return On Invested Capital of 6.81%. This is in the better half of the industry: BZ outperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA 8.21%
ROE 10.59%
ROIC 6.81%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.57%
ROE(5y)-5.83%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of BZ (21.54%) is better than 90.00% of its industry peers.
With an excellent Operating Margin value of 15.95%, BZ belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
The Gross Margin of BZ (83.15%) is better than 78.57% of its industry peers.
In the last couple of years the Gross Margin of BZ has remained more or less at the same level.
Industry RankSector Rank
OM 15.95%
PM (TTM) 21.54%
GM 83.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BZ is destroying value.
BZ has about the same amout of shares outstanding than it did 1 year ago.
BZ has more shares outstanding than it did 5 years ago.
BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.9
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 3.60 indicates that BZ has no problem at all paying its short term obligations.
The Current ratio of BZ (3.60) is better than 78.57% of its industry peers.
BZ has a Quick Ratio of 3.60. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
BZ has a Quick ratio of 3.60. This is in the better half of the industry: BZ outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.90% over the past year.
BZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.58%.
The Revenue has been growing by 49.09% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.67%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%15.4%

3.2 Future

BZ is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.51% yearly.
Based on estimates for the next years, BZ will show a quite strong growth in Revenue. The Revenue will grow by 12.58% on average per year.
EPS Next Y24.16%
EPS Next 2Y19.92%
EPS Next 3Y18.33%
EPS Next 5Y-2.51%
Revenue Next Year13.16%
Revenue Next 2Y13.37%
Revenue Next 3Y13.11%
Revenue Next 5Y12.58%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.49, the valuation of BZ can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of BZ indicates a somewhat cheap valuation: BZ is cheaper than 72.86% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BZ to the average of the S&P500 Index (28.29), we can say BZ is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.31 indicates a correct valuation of BZ.
Based on the Price/Forward Earnings ratio, BZ is valued a bit cheaper than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, BZ is valued a bit cheaper.
Industry RankSector Rank
PE 16.49
Fwd PE 13.31
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZ has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BZ's earnings are expected to grow with 18.33% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y19.92%
EPS Next 3Y18.33%

More info and screens

0

5. Dividend

5.1 Amount

BZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KANZHUN LTD - ADR

NASDAQ:BZ (4/21/2025, 12:28:09 PM)

13.52

-0.38 (-2.73%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-11 2025-03-11/bmo
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners75.9%
Inst Owner Change-0.48%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap5.96B
Analysts82.14
Price Target21.16 (56.51%)
Short Float %8.4%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.38%
Min EPS beat(2)-0.61%
Max EPS beat(2)9.37%
EPS beat(4)3
Avg EPS beat(4)7.36%
Min EPS beat(4)-0.61%
Max EPS beat(4)18.64%
EPS beat(8)7
Avg EPS beat(8)19.81%
EPS beat(12)10
Avg EPS beat(12)273.42%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-1.57%
Revenue beat(4)0
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)-0.6%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.62%
PT rev (3m)26.36%
EPS NQ rev (1m)1.81%
EPS NQ rev (3m)15.14%
EPS NY rev (1m)1.88%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 16.49
Fwd PE 13.31
P/S 5.92
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)0.82
EY6.07%
EPS(NY)1.02
Fwd EY7.51%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.28
BVpS4.65
TBVpS4.57
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.21%
ROE 10.59%
ROCE 7.76%
ROIC 6.81%
ROICexc 235.22%
ROICexgc 576.89%
OM 15.95%
PM (TTM) 21.54%
GM 83.15%
FCFM N/A
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.57%
ROE(5y)-5.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z N/A
F-ScoreN/A
WACC7.54%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.67%
EPS Next Y24.16%
EPS Next 2Y19.92%
EPS Next 3Y18.33%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%15.4%
Revenue Next Year13.16%
Revenue Next 2Y13.37%
Revenue Next 3Y13.11%
Revenue Next 5Y12.58%
EBIT growth 1Y101.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.97%
EBIT Next 3Y24.82%
EBIT Next 5Y19.2%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A